Cargando…

Critical review of multimorbidity outcome measures suitable for low-income and middle-income country settings: perspectives from the Global Alliance for Chronic Diseases (GACD) researchers

OBJECTIVES: There is growing recognition around the importance of multimorbidity in low-income and middle-income country (LMIC) settings, and specifically the need for pragmatic intervention studies to reduce the risk of developing multimorbidity, and of mitigating the complications and progression...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurst, John R, Agarwal, Gina, van Boven, Job F M, Daivadanam, Meena, Gould, Gillian Sandra, Wan-Chun Huang, Erick, Maulik, Pallab K, Miranda, J Jaime, Owolabi, M O, Premji, Shahirose Sadrudin, Soriano, Joan B, Vedanthan, Rajesh, Yan, Lijing, Levitt, Naomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478040/
https://www.ncbi.nlm.nih.gov/pubmed/32895277
http://dx.doi.org/10.1136/bmjopen-2020-037079
_version_ 1783579989667479552
author Hurst, John R
Agarwal, Gina
van Boven, Job F M
Daivadanam, Meena
Gould, Gillian Sandra
Wan-Chun Huang, Erick
Maulik, Pallab K
Miranda, J Jaime
Owolabi, M O
Premji, Shahirose Sadrudin
Soriano, Joan B
Vedanthan, Rajesh
Yan, Lijing
Levitt, Naomi
author_facet Hurst, John R
Agarwal, Gina
van Boven, Job F M
Daivadanam, Meena
Gould, Gillian Sandra
Wan-Chun Huang, Erick
Maulik, Pallab K
Miranda, J Jaime
Owolabi, M O
Premji, Shahirose Sadrudin
Soriano, Joan B
Vedanthan, Rajesh
Yan, Lijing
Levitt, Naomi
author_sort Hurst, John R
collection PubMed
description OBJECTIVES: There is growing recognition around the importance of multimorbidity in low-income and middle-income country (LMIC) settings, and specifically the need for pragmatic intervention studies to reduce the risk of developing multimorbidity, and of mitigating the complications and progression of multimorbidity in LMICs. One of many challenges in completing such research has been the selection of appropriate outcomes measures. A 2018 Delphi exercise to develop a core-outcome set for multimorbidity research did not specifically address the challenges of multimorbidity in LMICs where the global burden is greatest, patterns of disease often differ and health systems are frequently fragmented. We, therefore, aimed to summarise and critically review outcome measures suitable for studies investigating mitigation of multimorbidity in LMIC settings. SETTING: LMIC. PARTICIPANTS: People with multimorbidity. OUTCOME MEASURES: Identification of all outcome measures. RESULTS: We present a critical review of outcome measures across eight domains: mortality, quality of life, function, health economics, healthcare access and utilisation, treatment burden, measures of ‘Healthy Living’ and self-efficacy and social functioning. CONCLUSIONS: Studies in multimorbidity are necessarily diverse and thus different outcome measures will be appropriate for different study designs. Presenting the diversity of outcome measures across domains should provide a useful summary for researchers, encourage the use of multiple domains in multimorbidity research, and provoke debate and progress in the field.
format Online
Article
Text
id pubmed-7478040
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-74780402020-09-21 Critical review of multimorbidity outcome measures suitable for low-income and middle-income country settings: perspectives from the Global Alliance for Chronic Diseases (GACD) researchers Hurst, John R Agarwal, Gina van Boven, Job F M Daivadanam, Meena Gould, Gillian Sandra Wan-Chun Huang, Erick Maulik, Pallab K Miranda, J Jaime Owolabi, M O Premji, Shahirose Sadrudin Soriano, Joan B Vedanthan, Rajesh Yan, Lijing Levitt, Naomi BMJ Open Global Health OBJECTIVES: There is growing recognition around the importance of multimorbidity in low-income and middle-income country (LMIC) settings, and specifically the need for pragmatic intervention studies to reduce the risk of developing multimorbidity, and of mitigating the complications and progression of multimorbidity in LMICs. One of many challenges in completing such research has been the selection of appropriate outcomes measures. A 2018 Delphi exercise to develop a core-outcome set for multimorbidity research did not specifically address the challenges of multimorbidity in LMICs where the global burden is greatest, patterns of disease often differ and health systems are frequently fragmented. We, therefore, aimed to summarise and critically review outcome measures suitable for studies investigating mitigation of multimorbidity in LMIC settings. SETTING: LMIC. PARTICIPANTS: People with multimorbidity. OUTCOME MEASURES: Identification of all outcome measures. RESULTS: We present a critical review of outcome measures across eight domains: mortality, quality of life, function, health economics, healthcare access and utilisation, treatment burden, measures of ‘Healthy Living’ and self-efficacy and social functioning. CONCLUSIONS: Studies in multimorbidity are necessarily diverse and thus different outcome measures will be appropriate for different study designs. Presenting the diversity of outcome measures across domains should provide a useful summary for researchers, encourage the use of multiple domains in multimorbidity research, and provoke debate and progress in the field. BMJ Publishing Group 2020-09-06 /pmc/articles/PMC7478040/ /pubmed/32895277 http://dx.doi.org/10.1136/bmjopen-2020-037079 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Global Health
Hurst, John R
Agarwal, Gina
van Boven, Job F M
Daivadanam, Meena
Gould, Gillian Sandra
Wan-Chun Huang, Erick
Maulik, Pallab K
Miranda, J Jaime
Owolabi, M O
Premji, Shahirose Sadrudin
Soriano, Joan B
Vedanthan, Rajesh
Yan, Lijing
Levitt, Naomi
Critical review of multimorbidity outcome measures suitable for low-income and middle-income country settings: perspectives from the Global Alliance for Chronic Diseases (GACD) researchers
title Critical review of multimorbidity outcome measures suitable for low-income and middle-income country settings: perspectives from the Global Alliance for Chronic Diseases (GACD) researchers
title_full Critical review of multimorbidity outcome measures suitable for low-income and middle-income country settings: perspectives from the Global Alliance for Chronic Diseases (GACD) researchers
title_fullStr Critical review of multimorbidity outcome measures suitable for low-income and middle-income country settings: perspectives from the Global Alliance for Chronic Diseases (GACD) researchers
title_full_unstemmed Critical review of multimorbidity outcome measures suitable for low-income and middle-income country settings: perspectives from the Global Alliance for Chronic Diseases (GACD) researchers
title_short Critical review of multimorbidity outcome measures suitable for low-income and middle-income country settings: perspectives from the Global Alliance for Chronic Diseases (GACD) researchers
title_sort critical review of multimorbidity outcome measures suitable for low-income and middle-income country settings: perspectives from the global alliance for chronic diseases (gacd) researchers
topic Global Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478040/
https://www.ncbi.nlm.nih.gov/pubmed/32895277
http://dx.doi.org/10.1136/bmjopen-2020-037079
work_keys_str_mv AT hurstjohnr criticalreviewofmultimorbidityoutcomemeasuressuitableforlowincomeandmiddleincomecountrysettingsperspectivesfromtheglobalallianceforchronicdiseasesgacdresearchers
AT agarwalgina criticalreviewofmultimorbidityoutcomemeasuressuitableforlowincomeandmiddleincomecountrysettingsperspectivesfromtheglobalallianceforchronicdiseasesgacdresearchers
AT vanbovenjobfm criticalreviewofmultimorbidityoutcomemeasuressuitableforlowincomeandmiddleincomecountrysettingsperspectivesfromtheglobalallianceforchronicdiseasesgacdresearchers
AT daivadanammeena criticalreviewofmultimorbidityoutcomemeasuressuitableforlowincomeandmiddleincomecountrysettingsperspectivesfromtheglobalallianceforchronicdiseasesgacdresearchers
AT gouldgilliansandra criticalreviewofmultimorbidityoutcomemeasuressuitableforlowincomeandmiddleincomecountrysettingsperspectivesfromtheglobalallianceforchronicdiseasesgacdresearchers
AT wanchunhuangerick criticalreviewofmultimorbidityoutcomemeasuressuitableforlowincomeandmiddleincomecountrysettingsperspectivesfromtheglobalallianceforchronicdiseasesgacdresearchers
AT maulikpallabk criticalreviewofmultimorbidityoutcomemeasuressuitableforlowincomeandmiddleincomecountrysettingsperspectivesfromtheglobalallianceforchronicdiseasesgacdresearchers
AT mirandajjaime criticalreviewofmultimorbidityoutcomemeasuressuitableforlowincomeandmiddleincomecountrysettingsperspectivesfromtheglobalallianceforchronicdiseasesgacdresearchers
AT owolabimo criticalreviewofmultimorbidityoutcomemeasuressuitableforlowincomeandmiddleincomecountrysettingsperspectivesfromtheglobalallianceforchronicdiseasesgacdresearchers
AT premjishahirosesadrudin criticalreviewofmultimorbidityoutcomemeasuressuitableforlowincomeandmiddleincomecountrysettingsperspectivesfromtheglobalallianceforchronicdiseasesgacdresearchers
AT sorianojoanb criticalreviewofmultimorbidityoutcomemeasuressuitableforlowincomeandmiddleincomecountrysettingsperspectivesfromtheglobalallianceforchronicdiseasesgacdresearchers
AT vedanthanrajesh criticalreviewofmultimorbidityoutcomemeasuressuitableforlowincomeandmiddleincomecountrysettingsperspectivesfromtheglobalallianceforchronicdiseasesgacdresearchers
AT yanlijing criticalreviewofmultimorbidityoutcomemeasuressuitableforlowincomeandmiddleincomecountrysettingsperspectivesfromtheglobalallianceforchronicdiseasesgacdresearchers
AT levittnaomi criticalreviewofmultimorbidityoutcomemeasuressuitableforlowincomeandmiddleincomecountrysettingsperspectivesfromtheglobalallianceforchronicdiseasesgacdresearchers
AT criticalreviewofmultimorbidityoutcomemeasuressuitableforlowincomeandmiddleincomecountrysettingsperspectivesfromtheglobalallianceforchronicdiseasesgacdresearchers